Protein toxins from plants and bacteria: Probes for intracellular transport and tools in medicine

FEBS Letters

Volumn 584, Issue 12, 2010, Pages 2626-2634

  Sandvig, Kirsten ^a,b,c   Torgersen, Maria L ^a,b   Engedal, Nikolai ^a,b   Skotland, Tore ^a,b   Iversen, Tore Geir ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Endocytosis; Endoplasmic reticulum; Golgi apparatus; Ricin; Shiga toxin

Indexed keywords

BACTERIAL TOXIN; CALMODULIN; CELL SURFACE RECEPTOR; CONTACTIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; DENILEUKIN DIFTITOX; DIPHTHERIA TOXIN; DYNAMIN; MITOGEN ACTIVATED PROTEIN KINASE P38; NANOPARTICLE; PLANT TOXIN; PROSTAGLANDIN SYNTHASE; PROTEIN KINASE C; RETINA S ANTIGEN; RICIN; SHIGA TOXIN; TRANSFERRIN;

COMPLEX FORMATION; ENDOCYTOSIS; ENDOSOME; GOLGI COMPLEX; HUMAN; INTRACELLULAR TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CYTOSOL; DRUG CARRIERS; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; GOLGI APPARATUS; HUMANS; INTRACELLULAR SPACE; MEMBRANE LIPIDS; MODELS, MOLECULAR; MOLECULAR PROBES; NANOPARTICLES; NEOPLASMS; PROTEIN KINASES; RICIN; SHIGA TOXIN;

BACTERIA (MICROORGANISMS); EUKARYOTA;

EID: 77953127589     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.04.008     Document Type: Review

References (109)

1. Sandvig K., van Deurs B. Delivery into cells: lessons learned from plant and bacterial toxins. Gene Ther. 2005, 12:865-872.
2. Sandvig K., van Deurs B. Membrane traffic exploited by protein toxins. Ann. Rev. Cell Dev. Biol. 2002, 18:1-14.
3. Johannes L., Romer W. Shiga toxins - from cell biology to biomedical applications. Nat. Rev. Microbiol. 2010, 8:105-116.
4. Johannes L., Popoff V. Tracing the retrograde route in protein trafficking. Cell 2008, 135:1175-1187.
5. Badizadegan K., Wheeler H.E., Fujinaga Y., Lencer W.I. Trafficking of cholera toxin-ganglioside GM1 complex into the Golgi and the induction of toxicity depend on the actin cytoskeleton. Am. J. Physiol. Cell Physiol. 2004, 287:C1453-C1462.
6. Lingwood C.A., Manis A., Mahfoud R., Khan F., Binnington B., Mylvaganam M. New aspects of the regulation of glycosphingolipid receptor function. Chem. Phys. Lipids 2010, 163:27-35.
7. Sandvig, K., Bergan, J., Dyve, A.B., Skotland, T. and Torgersen, M.L. (in press). Endocytosis and retrograde transport of Shiga toxin. Toxicon.
8. Karmali M.A. Infection by Shiga toxin-producing Escherichia coli: an overview. Mol. Biotechnol. 2004, 26:117-122.
9. Palermo M.S., Exeni R.A., Fernandez G.C. Hemolytic uremic syndrome: pathogenesis and update of interventions. Expert. Rev. Anti. Infect. Ther. 2009, 7:697-707.
10. Tarr P.I., Gordon C.A., Chandler W.L. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005, 365:1073-1086.
11. Coopman V., De Leeuw M., Cordonnier J., Jacobs W. Suicidal death after injection of a castor bean extract (Ricinus communis L.). Forensic Sci. Int. 2009, 189:e13-e20.
12. Papaloucas M., Papaloucas C., Stergioulas A. Ricin and the assassination of Georgi Markov. Pak. J. Biol. Sci. 2008, 11:2370-2371.
13. Schep L.J., Temple W.A., Butt G.A., Beasley M.D. Ricin as a weapon of mass terror - separating fact from fiction. Environ. Int. 2009, 35:1267-1271.
14. Holzman D.C. Whatever happened to immunotoxins? Research, and hope, are still alive. J. Natl. Cancer Inst. 2009, 101:624-625.
15. Johannes L., Decaudin D. Protein toxins: intracellular trafficking for targeted therapy. Gene Ther. 2005, 12:1360-1368.
16. Kreitman R.J. Recombinant immunotoxins for the treatment of chemoresistant hematologic malignancies. Curr. Pharm. Des. 2009, 15:2652-2664.
17. Duvic M., Talpur R. Optimizing denileukin diftitox (Ontak) therapy. Future Oncol. 2008, 4:457-469.
18. Strebhardt K., Ullrich A. Paul Ehrlich's magic bullet concept: 100 years of progress. Nat. Rev. Cancer 2008, 8:473-480.
19. Ling H., Boodhoo A., Hazes B., Cummings M.D., Armstrong G.D., Brunton J.L., Read R.J. Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3. Biochemistry 1998, 37:1777-1788.
20. Windschiegl B., Orth A., Romer W., Berland L., Stechmann B., Bassereau P., Johannes L., Steinem C. Lipid reorganization induced by Shiga toxin clustering on planar membranes. PLoS ONE 2009, 4:e6238.
21. Lingwood C.A., Binnington B., Manis A., Branch D.R. Globotriaosyl ceramide receptor function - where membrane structure and pathology intersect. FEBS Lett. 2010, 584:1879-1886.
22. Hehnly H., Stamnes M. Regulating cytoskeleton-based vesicle motility. FEBS Lett. 2007, 581:2112-2118.
23. Hehnly H., Sheff D., Stamnes M. Shiga toxin facilitates its retrograde transport by modifying microtubule dynamics. Mol. Biol. Cell 2006, 17:4379-4389.
24. Hehnly H.A., Longhini K.M., Chen J.L., Stamnes M. Retrograde Shiga toxin trafficking is regulated by ARHGAP21 and Cdc42. Mol. Biol. Cell 2009, 20:4303-4312.
25. Römer W., Berland L., Chambon V., Gaus K., Windschiegl B., Tenza D., Aly M.R., Fraisier V., Florent J.C., Perrais D., Lamaze C., Raposo G., Steinem C., Sens P., Bassereau P., Johannes L. Shiga toxin induces tubular membrane invaginations for its uptake into cells. Nature 2007, 450:670-675.
26. Grimmer S., Spilsberg B., Hanada K., Sandvig K. Depletion of sphingolipids facilitates endosome to Golgi transport of ricin. Traffic 2006, 7:1243-1253.
27. Raa H.A., Grimmer S., Schwudke D., Bergan J., Wälchli S., Skotland T., Shevchenko A., Sandvig K. Glycosphingolipid requirements for endosome-to-Golgi transport of Shiga toxin. Traffic 2009, 10:868-882.
28. Spilsberg B., van Meer G., Sandvig K. Role of lipids in the retrograde pathway of ricin intoxication. Traffic 2003, 4:544-552.
29. Abi-Habib R.J., Liu S., Bugge T.H., Leppla S.H., Frankel A.E. A urokinase-activated recombinant diphtheria toxin targeting the granulocyte-macrophage colony-stimulating factor receptor is selectively cytotoxic to human acute myeloid leukemia blasts. Blood 2004, 104:2143-2148.
30. Frankel A.E., Powell B.L., Lilly M.B. Cancer Chemotherapy and Biological Response Modifiers 2002, 301-312. Elsevier Science B.V. G. Giaccone, R. Shcilsky, P. Sondel (Eds.).
31. Liu T.F., Hall P.D., Cohen K.A., Willingham M.C., Cai J., Thorburn A., Frankel A.E. Interstitial diphtheria toxin-epidermal growth factor fusion protein therapy produces regressions of subcutaneous human glioblastoma multiforme tumors in athymic nude mice. Clin. Cancer Res. 2005, 11:329-334.
32. Kreitman R.J. Immunotoxins for targeted cancer therapy. AAPS J. 2006, 8:E532-E551.
33. Kreitman R.J. Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies. BioDrugs 2009, 23:1-13.
34. Rosconi M.P., Zhao G., London E. Analyzing topography of membrane-inserted diphtheria toxin T domain using BODIPY-streptavidin: at low pH, helices 8 and 9 form a transmembrane hairpin but helices 5-7 form stable nonclassical inserted segments on the cis side of the bilayer. Biochemistry 2004, 43:9127-9139.
35. Sandvig K., Torgersen M.L., Raa H.A., van Deurs B. Clathrin-independent endocytosis: from nonexisting to an extreme degree of complexity. Histochem. Cell Biol. 2008, 129:267-276.
36. Mayor S., Pagano R.E. Pathways of clathrin-independent endocytosis. Nat. Rev. Mol. Cell Biol. 2007, 8:603-612.
37. Wieffer M., Maritzen T., Haucke V. SnapShot: endocytic trafficking. Cell 2009, 137:382-383.
38. Garred Ø., van Deurs B., Sandvig K. Furin-induced cleavage and activation of Shiga toxin. J. Biol. Chem. 1995, 270:10817-10821.
39. Gordon V.M., Leppla S.H. Proteolytic activation of bacterial toxins: role of bacterial and host cell proteases. Infect. Immun. 1994, 62:333-340.
40. Moya M., Dautry-Varsat A., Goud B., Louvard D., Boquet P. Inhibition of coated pit formation in Hep2 cells blocks the cytotoxicity of diphtheria toxin but not that of ricin. J. Cell Biol. 1985, 101:548-559.
41. Sandvig K., Olsnes S., Petersen O.W., van Deurs B. Acidification of the cytosol inhibits endocytosis from coated pits. J. Cell Biol. 1987, 105:679-689.
42. Damke H., Baba T., Warnock D.E., Schmid S.L. Induction of mutant dynamin specifically blocks endocytic coated vesicle formation. J. Cell Biol. 1994, 127:915-934.
43. Damke H., Baba T., van der Bliek A.M., Schmid S.L. Clathrin-independent pinocytosis is induced in cells overexpressing a temperature-sensitive mutant of dynamin. J. Cell Biol. 1995, 131:69-80.
44. Torgersen M.L., Skretting G., van Deurs B., Sandvig K. Internalization of cholera toxin by different endocytic mechanisms. J. Cell Sci. 2001, 114:3737-3747.
45. Lauvrak S.U., Torgersen M.L., Sandvig K. Efficient endosome-to-Golgi transport of Shiga toxin is dependent on dynamin and clathrin. J. Cell Sci. 2004, 117:2321-2331.
46. Sandvig K., Olsnes S., Brown J.E., Petersen O.W., van Deurs B. Endocytosis from coated pits of Shiga toxin: a glycolipid- binding protein from Shigella dysenteriae 1. J. Cell Biol. 1989, 108:1331-1343.
47. Garred O., Rodal S.K., van Deurs B., Sandvig K. Reconstitution of clathrin-independent endocytosis at the apical domain of permeabilized MDCK II cells: Requirement for a Rho-family GTPase. Traffic 2001, 2:26-36.
48. Hansen C.G., Bright N.A., Howard G., Nichols B.J. SDPR induces membrane curvature and functions in the formation of caveolae. Nat. Cell Biol. 2009, 11:807-814.
49. Lauvrak S.U., Wälchli S., Slagsvold H.H., Torgersen M.L., Spilsberg B., Sandvig K. Shiga toxin regulates its entry in a Syk-dependent manner. Mol. Biol. Cell 2006, 17:1096-1109.
50. Walchli S., Aasheim H.C., Skanland S.S., Spilsberg B., Torgersen M.L., Rosendal K.R., Sandvig K. Characterization of clathrin and Syk interaction upon Shiga toxin binding. Cell Signal. 2009, 21:1161-1168.
51. Cao H., Chen J., Krueger E.W., McNiven M.A. Src mediated phosphorylation of dynamin and cortactin regulates the " Constitutive" endocytosis of transferrin. Mol. Cell Biol. 2010, 30:781-792.
52. Torgersen M.L., Lauvrak S.U., Sandvig K. Shiga toxin A-chain stimulates clathrin-dependent uptake of the toxin. FEBS J. 2005, 272:4103-4113.
53. Mallard F., Antony C., Tenza D., Salamero J., Goud B., Johannes L. Direct pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of shiga toxin B-fragment transport. J. Cell Biol. 1998, 143:973-990.
54. Iversen T.-G., Skretting G., Llorente A., Nicoziani P., van Deurs B., Sandvig K. Endosome to Golgi transport of ricin is independent of clathrin and of the Rab9- and Rab11-GTPases. Mol. Biol. Cell 2001, 12:2099-2107.
55. Dyve A.B., Bergan J., Utskarpen A., Sandvig K. Sorting nexin 8 regulates endosome-to-Golgi transport. Biochem. Biophys. Res. Commun. 2009, 390:109-114.
56. Torgersen M.L., Engedal N., Bergan J., Sandvig K. The intracellular journey of Shiga toxins. Open Toxinol. J. 2010, 3:3-12.
57. Saint-Pol A., Yelamos B., Amessou M., Mills I.G., Dugast M., Tenza D., Schu P., Antony C., McMahon H.T., Lamaze C., Johannes L. Clathrin adaptor epsinR is required for retrograde sorting on early endosomal membranes. Dev. Cell 2004, 6:525-538.
58. Utskarpen A., Slagsvold H.H., Iversen T.-G., Wälchli S., Sandvig K. Retrograde transport of ricin is regulated by Rab6A/A' in a sequential manner. Traffic 2006, 7:663-672.
59. Skanland, S.S., Walchli, S., Brech, A. and Sandvig, K. (2009). SNX4 in complex with clathrin and dynein: implications for endosome movement. PLoS ONE e5935.
60. Skånland S.S., Wälchli S., Wandinger-Ness A., Sandvig K. Phosphoinositide-regulated retrograde transport of ricin: crosstalk between hVps34 and sorting nexins. Traffic 2007, 8:297-309.
61. van Weering J.R., Verkade P., Cullen P.J. SNX-BAR proteins in phosphoinositide-mediated, tubular-based endosomal sorting. Semin. Cell Dev. Biol. 2010, 21:371-380.
62. Bujny M.V., Popoff V., Johannes L., Cullen P.J. The retromer component sorting nexin-1 is required for efficient retrograde transport of Shiga toxin from early endosome to the trans Golgi network. J. Cell Sci. 2007, 120:2010-2021.
63. Popoff V., Mardones G.A., Tenza D., Rojas R., Lamaze C., Bonifacino J.S., Raposo G., Johannes L. The retromer complex and clathrin define an early endosomal retrograde exit site. J. Cell Sci. 2007, 120:2022-2031.
64. Utskarpen A., Slagsvold H.H., Dyve A.B., Skanland S.S., Sandvig K. SNX1 and SNX2 mediate retrograde transport of Shiga toxin. Biochem. Biophys. Res. Commun. 2007, 358:566-570.
65. Popoff V., Mardones G.A., Bai S.K., Chambon V., Tenza D., Burgos P.V., Shi A., Benaroch P., Urbe S., Lamaze C., Grant B.D., Raposo G., Johannes L. Analysis of articulation between clathrin and retromer in retrograde sorting on early endosomes. Traffic 2009, 10:1868-1880.
66. Torgersen M.L., Walchli S., Grimmer S., Skanland S.S., Sandvig K. PKCdelta is activated by Shiga toxin and regulates its transport. J. Biol. Chem. 2007, 282:16317-16328.
67. Skanland S.S., Walchli S., Sandvig K. Beta-arrestins attenuate p38 mediated endosome to Golgi transport. Cell Microbiol. 2009, 11:796-807.
68. Walchli S., Skanland S.S., Gregers T.F., Lauvrak S.U., Torgersen M.L., Ying M., Kuroda S., Maturana A., Sandvig K. The mitogen-activated protein kinase p38 links Shiga toxin-dependent signaling and trafficking. Mol. Biol. Cell 2008, 19:95-104.
69. Lingwood D., Simons K. Lipid rafts as a membrane-organizing principle. Science 2010, 327:46-50.
70. Parton R.G., Hanzal-Bayer M., Hancock J.F. Biogenesis of caveolae: a structural model for caveolin-induced domain formation. J. Cell Sci. 2006, 119:787-796.
71. Richter T., Floetenmeyer M., Ferguson C., Galea J., Goh J., Lindsay M.R., Morgan G.P., Marsh B.J., Parton R.G. High-resolution 3D quantitative analysis of caveolar ultrastructure and caveola-cytoskeleton interactions. Traffic 2008, 9:893-909.
72. Harder T., Kellner R., Parton R.G., Gruenberg J. Specific release of membrane-bound annexin II and cortical cytoskeletal elements by sequestration of membrane cholesterol. Mol. Biol. Cell 1997, 8:533-545.
73. Grimmer S., Iversen T.G., van Deurs B., Sandvig K. Endosome to Golgi transport of ricin is regulated by cholesterol. Mol. Biol. Cell 2000, 11:4205-4216.
74. Falguieres T., Mallard F., Baron C., Hanau D., Lingwood C., Goud B., Salamero J., Johannes L. Targeting of shiga toxin b-subunit to retrograde transport route in association with detergent-resistant membranes. Mol. Biol. Cell 2001, 12:2453-2468.
75. Sandvig K., Garred Ø., Prydz K., Kozlov J.V., Hansen S.H., van Deurs B. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature 1992, 358:510-511.
76. Sandvig K., Garred O., van Helvoort A., van Meer G., van Deurs B. Importance of glycolipid synthesis for butyric acid-induced sensitization to Shiga toxin and intracellular sorting of toxin in A431 cells. Mol. Biol. Cell 1996, 7:1391-1404.
77. Sandvig K., Garred Ø., van Deurs B. Regulated transport of cholera toxin to the endoplasmic reticulum: correlation with cAMP production. Proc. Natl. Acad. Sci. USA 1996, 93:12339-12343.
78. Rapak A., Falnes P.O., Olsnes S. Retrograde transport of mutant ricin to the endoplasmic reticulum with subsequent translocation to cytosol. Proc. Natl. Acad. Sci. USA 1997, 94:3783-3788.
79. Smith D.C., Sillence D.J., Falguieres T., Jarvis R.M., Johannes L., Lord J.M., Platt F.M., Roberts L.M. The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect. Mol. Biol. Cell 2006, 17:1375-1387.
80. Falguieres T., Romer W., Amessou M., Afonso C., Wolf C., Tabet J.C., Lamaze C., Johannes L. Functionally different pools of Shiga toxin receptor, globotriaosyl ceramide, in HeLa cells. FEBS J. 2006, 273:5205-5218.
81. Arab S., Lingwood C.A. Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to verotoxin via globotriasyl ceramide fatty acid isoform traffic. J. Cell. Physiol. 1998, 177:646-660.
82. Arab S., Murakami M., Dirks P., Boyd B., Hubbard S.L., Lingwood C.A., Rutka J.T. Verotoxins inhibit the growth of and induce apoptosis in human astrocytoma cells. J. Neurooncol. 1998, 40:137-150.
83. Muthing J., Schweppe C.H., Karch H., Friedrich A.W. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury. Thromb. Haemost. 2009, 101:252-264.
84. Schweppe C.H., Bielaszewska M., Pohlentz G., Friedrich A.W., Buntemeyer H., Schmidt M.A., Kim K.S., Peter-Katalinic J., Karch H., Muthing J. Glycosphingolipids in vascular endothelial cells: relationship of heterogeneity in Gb3Cer/CD77 receptor expression with differential Shiga toxin 1 cytotoxicity. Glycoconj. J. 2008, 25:291-304.
85. Spilsberg B., Llorente A., Sandvig K. Polyunsaturated fatty acids regulate Shiga toxin transport. Biochem. Biophys. Res. Commun. 2007, 364:283-288.
86. Jackson C.L. Mechanisms of transport through the Golgi complex. J. Cell Sci. 2009, 122:443-452.
87. Girod A., Storrie B., Simpson J.C., Johannes L., Goud B., Roberts L.M., Lord J.M., Nilsson T., Pepperkok R. Evidence for a COP-I-independent transport route from the Golgi complex to the endoplasmic reticulum. Nat. Cell Biol. 1999, 1:423-430.
88. White J., Johannes L., Mallard F., Girod A., Grill S., Reinsch S., Keller P., Tzschaschel B., Echard A., Goud B., Stelzer H.K. Rab6 coordinates a novel Golgi to ER retrograde transport pathway in live cells. J. Cell Biol. 1999, 147:743-760.
89. del Nery E., Miserey-Lenkei S., Falguieres T., Nizak C., Johannes L., Perez F., Goud B. Rab6A and Rab6A' GTPases play non-overlapping roles in membrane trafficking. Traffic 2006, 7:394-407.
90. Duran J.M., Valderrama F., Castel S., Magdalena J., Tomas M., Hosoya H., Renau-Piqueras J., Malhotra V., Egea G. Myosin motors and not actin comets are mediators of the actin-based golgi-to-endoplasmic reticulum protein transport. Mol. Biol. Cell 2003, 14:445-459.
91. Luna A., Matas O.B., Martinez-Menárguez J.A., Mato E., Duran J.M., Ballesta J., Way M., Egea G. Regulation of protein transport from the Golgi complex to the endoplasmic reticulum by CDC42 and N-WASP. Mol. Biol. Cell 2002, 13:866-879.
92. Valderrama F., Duran J.M., Babia T., Barth H., Renau-Piqueras J., Egea G. Actin microfilaments facilitate the retrograde transport from the Golgi complex to the endoplasmic reticulum in mammalian cells. Traffic 2001, 2:717-726.
93. Kano F., Yamauchi S., Yoshida Y., Watanabe-Takahashi M., Nishikawa K., Nakamura N., Murata M. Yip1A regulates the COPI-independent retrograde transport from the Golgi complex to the ER. J. Cell Sci. 2009, 122:2218-2227.
94. Llorente A., Lauvrak S.U., van Deurs B., Sandvig K. Induction of direct endosome to endoplasmic reticulum transport in Chinese hamster ovary (CHO) cells (LdlF) with a temperature-sensitive defect in epsilon-coatomer protein (epsilon-COP). J. Biol. Chem. 2003, 278:35850-35855.
95. Jackson M.E., Simpson J.C., Girod A., Pepperkok R., Roberts L.M., Lord J.M. The KDEL retrieval system is exploited by Pseudomonas exotoxin A, but not by Shiga-like toxin-1, during retrograde transport from the Golgi complex to the endoplasmic reticulum. J. Cell Sci. 1999, 112:467-475.
96. Bard F., Mazelin L., Pechoux-Longin C., Malhotra V., Jurdic P. Src regulates Golgi structure and KDEL receptor-dependent retrograde transport to the endoplasmic reticulum. J. Biol. Chem. 2003, 278:46601-46606.
97. Pulvirenti T., Giannotta M., Capestrano M., Capitani M., Pisanu A., Polishchuk R.S., San Pietro E., Beznoussenko G.V., Mironov A.A., Turacchio G., Hsu V.W., Sallese M., Luini A. A traffic-activated Golgi-based signalling circuit coordinates the secretory pathway. Nat. Cell Biol. 2008, 10:912-922.
98. Yu M., Haslam D.B. Shiga toxin is transported from the endoplasmic reticulum following interaction with the luminal chaperone HEDJ/ERdj3. Infect. Immun. 2005, 73:2524-2532.
99. Slominska-Wojewodska M., Gregers T.F., Wälchli S., Sandvig K. EDEM is involved in translocation of ricin from the endoplasmic reticulum to the cytosol. Mol. Biol. Cell 2006, 17:1664-1675.
100. Iversen T.-G., Frerker N., Sandvig K. Quantum dot bioconjugates: uptake into cells and induction of changes in normal cellular transport. Progress Biomed. Opt. Imag. 2009, 7189:71890T-9.
101. Ehrlich P. The Collected Papers of Paul Ehrlich 1957, 596-618. Pergamon Press. F. Himmelweit, M. Marquardt, S.S. Dale (Eds.).
102. Kreitman R.J. Recombinant immunotoxins for the treatment of haematological malignancies. Expert. Opin. Biol. Ther. 2004, 4:1115-1128.
103. Wong B.Y., Gregory S.A., Dang N.H. Denileukin diftitox as novel targeted therapy for lymphoid malignancies. Cancer Invest. 2007, 25:495-501.
104. Doherty S.D., Prieto V.G., George S., Hazarika P., Duvic M. High flotillin-2 expression is associated with lymph node metastasis and Breslow depth in melanoma. Melanoma Res. 2006, 16:461-463.
105. Potala S., Sahoo S.K., Verma R.S. Targeted therapy of cancer using diphtheria toxin-derived immunotoxins. Drug Discov. Today 2008, 13:807-815.
106. Facchini L.M., Lingwood C.A. A verotoxin 1 B subunit-lambda CRO chimeric protein specifically binds both DNA and globotriaosylceramide (Gb(3)) to effect nuclear targeting of exogenous DNA in Gb(3) positive cells. Exp. Cell Res. 2001, 269:117-129.
107. Distler U., Souady J., Hulsewig M., Drmic-Hofman I., Haier J., Friedrich A.W., Karch H., Senninger N., Dreisewerd K., Berkenkamp S., Schmidt M.A., Peter-Katalinic J., Muthing J. Shiga toxin receptor Gb3Cer/CD77: tumor-association and promising therapeutic target in pancreas and colon cancer. PLoS ONE 2009, 4:e6813.
108. Kovbasnjuk O., Mourtazina R., Baibakov B., Wang T., Elowsky C., Choti M.A., Kane A., Donowitz M. The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer. Proc. Natl. Acad. Sci. USA 2005, 102:19087-19092.
109. Moreland J.L., Gramada A., Buzko O.V., Zhang Q., Bourne P.E. The Molecular Biology Toolkit (MBT): a modular platform for developing molecular visualization applications. BMC Bioinform. 2005, 6:21.